197 related articles for article (PubMed ID: 37399012)
1. Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury.
Gonzalez-Ortiz F; Dulewicz M; Ashton NJ; Kac PR; Zetterberg H; Andersson E; Yakoub Y; Hanrieder J; Turton M; Harrison P; Nellgård B; Karikari TK; Blennow K
JAMA Netw Open; 2023 Jul; 6(7):e2321554. PubMed ID: 37399012
[TBL] [Abstract][Full Text] [Related]
2. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
[TBL] [Abstract][Full Text] [Related]
3. Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers.
Rubenstein R; Chang B; Yue JK; Chiu A; Winkler EA; Puccio AM; Diaz-Arrastia R; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Davies P; Agarwal S; Lin F; Sarkis G; Yadikar H; Yang Z; Manley GT; Wang KKW; ; Cooper SR; Dams-O'Connor K; Borrasso AJ; Inoue T; Maas AIR; Menon DK; Schnyer DM; Vassar MJ
JAMA Neurol; 2017 Sep; 74(9):1063-1072. PubMed ID: 28738126
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of serum total tau following paediatric traumatic brain injury: a case-control study.
Stukas S; Higgins V; Frndova H; Gill J; Hubara E; Guerguerian AM; Boutis K; Beauchamp M; Farrell C; Babl FE; Delzoppo C; Greenham M; Wilkinson AA; Crichton A; Anderson V; Adeli K; Hutchison J; Wellington C; ; ;
Lancet Child Adolesc Health; 2019 Aug; 3(8):558-567. PubMed ID: 31231066
[TBL] [Abstract][Full Text] [Related]
5. Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury.
Andersson E; Öst M; Dalla K; Zetterberg H; Blennow K; Nellgård B
Neurocrit Care; 2024 May; ():. PubMed ID: 38769253
[TBL] [Abstract][Full Text] [Related]
6. A prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury.
Pandey S; Singh K; Sharma V; Pandey D; Jha RP; Rai SK; Chauhan RS; Singh R
Br J Neurosurg; 2017 Jun; 31(3):356-363. PubMed ID: 28293977
[TBL] [Abstract][Full Text] [Related]
7. Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.
Gonzalez MC; Ashton NJ; Gomes BF; Tovar-Rios DA; Blanc F; Karikari TK; Mollenhauer B; Pilotto A; Lemstra A; Paquet C; Abdelnour C; Kramberger MG; Bonanni L; Vandenberghe R; Hye A; Blennow K; Zetterberg H; Aarsland D;
JAMA Neurol; 2022 Jan; 79(1):32-37. PubMed ID: 34807233
[TBL] [Abstract][Full Text] [Related]
8. Temporal Profiles of P-Tau, T-Tau, and P-Tau:Tau Ratios in Cerebrospinal Fluid and Blood from Moderate-Severe Traumatic Brain Injury Patients and Relationship to 6-12 Month Global Outcomes.
Rubenstein R; McQuillan L; Wang KKW; Robertson C; Chang B; Yang Z; Xu H; Williamson J; Wagner AK
J Neurotrauma; 2024 Feb; 41(3-4):369-392. PubMed ID: 37725589
[TBL] [Abstract][Full Text] [Related]
9. Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study.
Wu X; Su C; Tian D; Ye Y; Du Q; Chen J; Li H; Liu J
Brain Behav; 2024 May; 14(5):e3522. PubMed ID: 38773776
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest.
Ashton NJ; Moseby-Knappe M; Benedet AL; Grötschel L; Lantero-Rodriguez J; Karikari TK; Hassager C; Wise MP; Stammet P; Kjaergaard J; Friberg H; Nielsen N; Cronberg T; Zetterberg H; Blennow K
JAMA Neurol; 2023 Apr; 80(4):388-396. PubMed ID: 36877496
[TBL] [Abstract][Full Text] [Related]
11. Admission levels of serum biomarkers have additive and cumulative prognostic value in traumatic brain injury.
Kaaber IA; Lesbo M; Wichmann TO; Olsen DA; Rasmussen MM; Brink O; Borris LC; Hviid CVB
Sci Rep; 2024 Jun; 14(1):14139. PubMed ID: 38898030
[TBL] [Abstract][Full Text] [Related]
12. Dynamic change in cortisol levels associated with severity, progression, and survival of patients with traumatic brain injury.
Srivastava A; Chandra A; Yadav A; Ojha BK; Srivastava C; Verma R; Ali W
Clin Neurol Neurosurg; 2022 Nov; 222():107419. PubMed ID: 36058182
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Diagnostic Utility of Serum Biomarkers in Pediatric Traumatic Brain Injury.
Munoz Pareja JC; de Rivero Vaccari JP; Chavez MM; Kerrigan M; Pringle C; Guthrie K; Swaby K; Coto J; Kobeissy F; Avery KL; Ghosh S; Dhanashree R; Shanmugham P; Lautenslager LA; Faulkenberry S; Pareja Zabala MC; Al Fakhri N; Loor-Torres R; Governale LS; Blatt JE; Gober J; Perez PK; Solano J; McCrea H; Thorson C; O'Phelan KH; Keane RW; Dietrich WD; Wang KK
J Neurotrauma; 2024 Jan; 41(1-2):106-122. PubMed ID: 37646421
[TBL] [Abstract][Full Text] [Related]
14. Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV.
Li X; Yucel R; Clervius H; Kamalakar K; Zetterberg H; Blennow K; Zhang J; Adimora A; Collins LF; Fischl M; Kassaye S; Maki P; Seaberg E; Sharma A; Vance D; Gustafson DR
JAMA Netw Open; 2023 Nov; 6(11):e2344194. PubMed ID: 38019518
[TBL] [Abstract][Full Text] [Related]
15. Routine Blood Tests for Severe Traumatic Brain Injury: Can They Predict Outcomes?
Dolmans RGF; Hulsbergen AFC; Gormley WB; Broekman MLD
World Neurosurg; 2020 Apr; 136():e60-e67. PubMed ID: 31655234
[TBL] [Abstract][Full Text] [Related]
16. Serum GFAP, NfL, and tau concentrations are associated with worse neurobehavioral functioning following mild, moderate, and severe TBI: a cross-sectional multiple-cohort study.
Edwards KA; Lange RT; Lippa SM; Brickell TA; Gill JM; French LM
Front Neurol; 2023; 14():1223960. PubMed ID: 38292036
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of severe traumatic brain injury and the predictive value of serum translocator protein combined with the reverse shock index multiplied by Glasgow Coma Scale].
Chen X; Zhu L
Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(3):218-223. PubMed ID: 33455149
[No Abstract] [Full Text] [Related]
18. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
Lange RT; Lippa S; Brickell TA; Gill J; French LM
J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes After Traumatic Brain Injury and Exposure to Extracranial Surgery: A TRACK-TBI Study.
Roberts CJ; Barber J; Temkin NR; Dong A; Robertson CS; Valadka AB; Yue JK; Markowitz AJ; Manley GT; Nelson LD; ; Badjatia N; Diaz-Arrastia R; Duhaime AC; Feeser VR; Gopinath S; Grandhi R; Jha R; Keene CD; Madden C; McCrea M; Merchant R; Ngwenya LB; Rodgers RB; Schnyer D; Taylor SR; Zafonte R
JAMA Surg; 2024 Mar; 159(3):248-259. PubMed ID: 38091011
[TBL] [Abstract][Full Text] [Related]
20. [Combination of apparent diffusion coefficient and amplitude-integrated electroencephalogram to predict the outcome of comatose patients with severe traumatic brain injury].
Song C; Li J; Xu H; Xu F; Zhong Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):609-612. PubMed ID: 34112303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
